InvestSMART

Biotron Limited (ASX: BIT) - Announcements

- Current share price for BIT : $0.002

ASX company news and announcements for Biotron Limited (BIT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Biotron Limited (BIT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Biotron Limited (BIT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Biotron Limited (BIT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Appendix 4C - quarterly 16 Jan 2017 12:53AM $0.038 $0.002 fallen by 94.74%
$6 Corrected Presentation to Biotech Showcase 2017 13 Jan 2017 3:19PM $0.039 $0.002 fallen by 94.87%
$6 Biotron Presents at Biotech Showcase 2017 13 Jan 2017 9:31AM $0.040 $0.002 fallen by 95%
$6 Results of Meeting 22 Nov 2016 1:24PM $0.049 $0.002 fallen by 95.92%
$6 AGM Presentation 22 Nov 2016 11:16AM $0.049 $0.002 fallen by 95.92%
$6 Annual report and Notice of Annual General Meeting 17 Oct 2016 12:26AM $0.046 $0.002 fallen by 95.65%
$6 Appendix 4C - quarterly 17 Oct 2016 12:23AM $0.046 $0.002 fallen by 95.65%
$6 Change of Director's Interest Notice 5 Oct 2016 10:12AM $0.047 $0.002 fallen by 95.74%
$6 Appendix 3B 5 Oct 2016 10:07AM $0.047 $0.002 fallen by 95.74%
$6 Clarification Statement 5 Sep 2016 10:06AM $0.063 $0.002 fallen by 96.83%
$6 Option Expiry Notice 2 Sep 2016 12:21AM $0.062 $0.002 fallen by 96.77%
$6 Zika Virus Program Update 22 Aug 2016 11:35AM $0.065 $0.002 fallen by 96.92%
$6 Full Year Statutory Accounts 5 Aug 2016 5:56PM $0.060 $0.002 fallen by 96.67%
$6 Appendix 4G and Corporate Governance Statement 5 Aug 2016 5:37PM $0.060 $0.002 fallen by 96.67%
$6 Appendix 3B 15 Jul 2016 11:36AM $0.059 $0.002 fallen by 96.61%
$6 Appendix 4C - quarterly 8 Jul 2016 9:29AM $0.059 $0.002 fallen by 96.61%
$6 Appendix 3B 7 Jul 2016 8:48AM $0.059 $0.002 fallen by 96.61%
$6 Biotron compounds demonstrate activity against Zika virus 23 May 2016 10:14AM $0.061 $0.002 fallen by 96.72%
$6 Presentation at Biotech Invest 2016 4 May 2016 9:58AM $0.060 $0.002 fallen by 96.67%
$6 $1.5 Million R&D Tax Rebate 20 Apr 2016 10:13AM $0.065 $0.002 fallen by 96.92%
$6 Appendix 4C - quarterly 20 Apr 2016 10:11AM $0.065 $0.002 fallen by 96.92%
$6 Letter to Shareholders 12 Apr 2016 11:59AM $0.062 $0.002 fallen by 96.77%
$6 Phase 2 Hepatitis C Trial Success 17 Mar 2016 10:51AM $0.063 $0.002 fallen by 96.83%
$6 Half Yearly Report and Accounts 26 Feb 2016 1:06PM $0.058 $0.002 fallen by 96.55%
$6 BIT225 MAY HAVE A BROADER ROLE IN LIMITING HIV-1 INFECTION 18 Feb 2016 11:09AM $0.059 $0.002 fallen by 96.61%

401 - 425 of 597 results

Page 17 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.